Overview
Bringing AI to one of the hardest problems in clinical trials
Confia was engaged to build relevance with a global pharmaceutical leader. The approach on LinkedIn shifted:
Before
general AI and engineering messaging with no specific pharmaceutical angle.
Now
a single-account ABM programme built around a real clinical-trial challenge and a clear Agentic AI framework.
The challenge
Pharmaceutical leaders are cautious buyers. They respond to partners who understand their specific operational challenges, not to broad AI claims.
Patient recruitment for clinical trials is one of those challenges. The programme needed a credible, specific point of view on how AI could help, delivered directly to the right people inside one organisation.
The approach
1. Warming the account with thought leadership. Confia ran precision-targeted Sponsored Content on data readiness and data modernisation to build familiarity ahead of account-level outreach.
2. A point of view built for pharma. Bespoke single-account creative featured a case note presenting a strategic framework for using Agentic AI in clinical-trial patient recruitment.
3. Measurement that matters. Programme KPIs were anchored on three measures: Revenue, Reputation and Relationships.
The results
1. A Fortune Global 500 pharmaceutical leader engaged with fully bespoke creative
2. A clear Agentic AI point of view on clinical-trial patient recruitment
3. A clear measurement framework built on Revenue, Reputation and Relationships
3
KPIS: REVENUE · REPUTATION · RELATIONSHIPS
Agentic AI
CLINICAL-TRIAL POV
1
FORTUNE GLOBAL 500 ACCOUNT
At a glance
Industry
Pharmaceuticals
Target
Fortune Global 500 pharma leader
Services
ABM, LinkedIn Ads